46 related articles for article (PubMed ID: 20884007)
1. Bioavailability of Reduced Coenzyme Q10 (Ubiquinol-10) in Burn Patients.
Kuriyama N; Nakamura T; Nakazawa H; Wen T; Berra L; Bittner EA; Goverman J; Kaneki M
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888737
[TBL] [Abstract][Full Text] [Related]
2. Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021.
Izar MCO; Giraldez VZR; Bertolami A; Santos Filho RDD; Lottenberg AM; Assad MHV; Saraiva JFK; Chacra APM; Martinez TLR; Bahia LR; Fonseca FAH; Faludi AA; Sposito AC; Chagas ACP; Jannes CE; Amaral CK; Araújo DB; Cintra DE; Coutinho EDR; Cesena F; Xavier HT; Mota ICP; Giuliano ICB; Faria Neto JR; Kato JT; Bertolami MC; Miname MH; Castelo MHCG; Lavrador MSF; Machado RM; Souza PG; Alves RJ; Machado VA; Salgado Filho W
Arq Bras Cardiol; 2021 Oct; 117(4):782-844. PubMed ID: 34709306
[No Abstract] [Full Text] [Related]
3. Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia.
Motkowski R; Maciejczyk M; Hryniewicka M; Karpińska J; Mikołuć B
Cardiovasc Drugs Ther; 2022 Feb; 36(1):75-84. PubMed ID: 33052507
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin improves mitochondrial respiration in peripheral blood cells.
Durhuus JA; Hansson S; Morville T; Kuhlman AB; Dohlmann TL; Larsen S; Helge JW; Angleys M; Muniesa-Vargas A; Bundgaard JR; Hickson ID; Dela F; Desler C; Rasmussen LJ
Sci Rep; 2020 Oct; 10(1):17012. PubMed ID: 33046789
[TBL] [Abstract][Full Text] [Related]
5. Drug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions.
Will Y; Shields JE; Wallace KB
Biology (Basel); 2019 May; 8(2):. PubMed ID: 31083551
[TBL] [Abstract][Full Text] [Related]
6. Statins, Muscle Disease and Mitochondria.
Ramachandran R; Wierzbicki AS
J Clin Med; 2017 Jul; 6(8):. PubMed ID: 28757597
[TBL] [Abstract][Full Text] [Related]
7. Drug-Induced Mitochondrial Toxicity.
Hargreaves IP; Al Shahrani M; Wainwright L; Heales SJ
Drug Saf; 2016 Jul; 39(7):661-74. PubMed ID: 26992920
[TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering efficacy of rosuvastatin.
Adams SP; Sekhon SS; Wright JM
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010254. PubMed ID: 25415541
[TBL] [Abstract][Full Text] [Related]
9. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.
Desbats MA; Lunardi G; Doimo M; Trevisson E; Salviati L
J Inherit Metab Dis; 2015 Jan; 38(1):145-56. PubMed ID: 25091424
[TBL] [Abstract][Full Text] [Related]
10. Mitophagy is required for acute cardioprotection by simvastatin.
Andres AM; Hernandez G; Lee P; Huang C; Ratliff EP; Sin J; Thornton CA; Damasco MV; Gottlieb RA
Antioxid Redox Signal; 2014 Nov; 21(14):1960-73. PubMed ID: 23901824
[TBL] [Abstract][Full Text] [Related]
11. Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study.
Coppadoro A; Berra L; Kumar A; Pinciroli R; Yamada M; Schmidt UH; Bittner EA; Kaneki M
J Crit Care; 2013 Oct; 28(5):571-6. PubMed ID: 23618779
[TBL] [Abstract][Full Text] [Related]
12. The role of nutraceutical supplements in the treatment of dyslipidemia.
Houston M
J Clin Hypertens (Greenwich); 2012 Feb; 14(2):121-132. PubMed ID: 22277145
[TBL] [Abstract][Full Text] [Related]
13. Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects.
Puccetti L; Scarpini F; Auteri A; Ciani F
J Pediatr; 2011 Mar; 158(3):520-1. PubMed ID: 21276592
[No Abstract] [Full Text] [Related]
14. Rosuvastatin calcium.
Quirk J; Thornton M; Kirkpatrick P
Nat Rev Drug Discov; 2003 Oct; 2(10):769-70. PubMed ID: 14579811
[No Abstract] [Full Text] [Related]
15. Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Gazi I; Kostara C; Bairaktari ET; Elisaf M
J Clin Pharmacol; 2006 Nov; 46(11):1337-43. PubMed ID: 17050799
[TBL] [Abstract][Full Text] [Related]
16. [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism].
Rákóczi K; Párdutz A; Vécsei L
Ideggyogy Sz; 2007 Jul; 60(7-8):295-300. PubMed ID: 17713110
[TBL] [Abstract][Full Text] [Related]
17. [Rosuvastatin: pharmacologic features].
Bernini F; Catapano AL
Ital Heart J; 2003 Dec; 4 Suppl 7():22S-32S. PubMed ID: 14983744
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia.
Avis HJ; Hargreaves IP; Ruiter JP; Land JM; Wanders RJ; Wijburg FA
J Pediatr; 2011 Mar; 158(3):458-62. PubMed ID: 20884007
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
